[go: up one dir, main page]

AU2001274998A1 - Production and use of derivatized homoserine lactones - Google Patents

Production and use of derivatized homoserine lactones

Info

Publication number
AU2001274998A1
AU2001274998A1 AU2001274998A AU7499801A AU2001274998A1 AU 2001274998 A1 AU2001274998 A1 AU 2001274998A1 AU 2001274998 A AU2001274998 A AU 2001274998A AU 7499801 A AU7499801 A AU 7499801A AU 2001274998 A1 AU2001274998 A1 AU 2001274998A1
Authority
AU
Australia
Prior art keywords
derivatized
production
homoserine lactones
homoserine
lactones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274998A
Inventor
Steven C. Quay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K-Quay Enterprises LLC
Original Assignee
QUAY ENTPR K LLC
K-Quay Enterprises LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QUAY ENTPR K LLC, K-Quay Enterprises LLC filed Critical QUAY ENTPR K LLC
Publication of AU2001274998A1 publication Critical patent/AU2001274998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001274998A 2000-06-02 2001-05-25 Production and use of derivatized homoserine lactones Abandoned AU2001274998A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/587,116 US6703513B1 (en) 2000-06-02 2000-06-02 Production and use of derivatized homoserine lactones
US09587116 2000-06-02
PCT/US2001/017272 WO2001094543A2 (en) 2000-06-02 2001-05-25 Production and use of derivatized homoserine lactones

Publications (1)

Publication Number Publication Date
AU2001274998A1 true AU2001274998A1 (en) 2001-12-17

Family

ID=24348424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274998A Abandoned AU2001274998A1 (en) 2000-06-02 2001-05-25 Production and use of derivatized homoserine lactones

Country Status (4)

Country Link
US (3) US6703513B1 (en)
EP (1) EP1299118A4 (en)
AU (1) AU2001274998A1 (en)
WO (1) WO2001094543A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1528935T3 (en) * 2002-08-13 2012-07-09 Haptogen Ltd Method of treating a bacterial infectious disease with antibodies against lactone or against lactone-derived signaling molecules
US7498292B2 (en) 2002-08-15 2009-03-03 The Research Foundation Of State University Of New York Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
DE10260929B4 (en) * 2002-12-20 2005-06-30 Henkel Kgaa Method of controlling processes based on microbial interaction
DE10361457A1 (en) 2003-12-23 2005-07-28 Henkel Kgaa New alkoxylactones, alkoxylactams and alkoxythiolactams
GB0407008D0 (en) * 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) * 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
US20090215079A1 (en) * 2005-12-05 2009-08-27 Technische Universitat Dresden Method and Devices for the Detection of Microorganisms and/or the Activity Thereof
DE102006057975B4 (en) * 2005-12-05 2009-06-10 Technische Universität Dresden Method and device for detecting microorganisms and / or their activity
KR100841333B1 (en) 2006-11-22 2008-06-25 재단법인서울대학교산학협력재단 Antimicrobial Homoserine Lactone Derivatives and Microbial Removal Methods Using the Same
KR100841289B1 (en) 2006-11-30 2008-06-25 재단법인서울대학교산학협력재단 Antimicrobial Homoserine Lactone Derivatives and Biofilm Formation Prevention Methods Using the Same
WO2009036081A1 (en) * 2007-09-10 2009-03-19 University Of Kentucky Research Foundation Systems and methods for diagnosis and monitoring of bacteria-related conditions
JP5318521B2 (en) * 2007-10-17 2013-10-16 花王株式会社 Quantification method of auto inducer-2
US20100121187A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US20100119455A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
US8535261B2 (en) * 2008-11-10 2013-09-17 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US8591454B2 (en) * 2008-11-10 2013-11-26 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US20100121581A1 (en) * 2008-11-10 2010-05-13 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Administering a therapeutic agent with more than one taggant
WO2011001419A1 (en) * 2009-07-03 2011-01-06 National Institute For Biotechnology In The Negev Covalent inhibition of bacterial quorum sensing
WO2013142372A1 (en) * 2012-03-20 2013-09-26 Kci Licensing, Inc. Targeted enzymatic degradation of quorum-sensing peptides
DE102013211850A1 (en) * 2013-06-21 2014-12-24 Gilupi Gmbh Rapid test for detection of pathogen material, in particular to support the diagnosis of sepsis, and kit and device for performing a sepsis test
WO2016176146A1 (en) * 2015-04-26 2016-11-03 The Trustees Of Princeton University Surfaces comprising attached quorum sensing modulators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108307D0 (en) 1991-04-18 1991-06-05 Univ Nottingham Autoinducer
CA2153661A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
GB9311641D0 (en) 1993-06-01 1993-07-21 Univ Warwick Process for activating gene expression in bacteria
CA2166289A1 (en) * 1993-07-02 1995-01-12 Barrie Walsham Bycroft Immunosuppressant and antiallergic compounds e.g. n-(3-oxohexanoyl) homoserine lactone
US5591872A (en) 1993-08-09 1997-01-07 The University Of Iowa Research Foundation Autoinducer molecule
WO1995025086A1 (en) * 1994-03-15 1995-09-21 Eisai Co., Ltd. Isoprenyl transferase inhibitors
EP0793673A1 (en) * 1994-11-24 1997-09-10 Takeda Chemical Industries, Ltd. Alpha-ketoamide derivatives as cathepsin l inhibitor
AUPN191295A0 (en) 1995-03-23 1995-04-27 Unisearch Limited Microbiocide or microbial regulator
US5759798A (en) * 1995-12-08 1998-06-02 Woods Hole Oceanographic Institution Assays, test kits and bacteria for detection of autoinducers
DE69836218T2 (en) * 1997-06-18 2007-09-06 Montana State University - Bozeman HOMOSERINLACTONS FOR REGULATING BIOFILMS AND METHODS OF USE
GB9725599D0 (en) * 1997-12-04 1998-02-04 Univ Nottingham Control of biofilm formation
US6395282B1 (en) * 1998-04-16 2002-05-28 University Of Rochester Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
GB0007588D0 (en) * 2000-03-30 2000-05-17 Univ Nottingham N-Acyl homoserine lactones

Also Published As

Publication number Publication date
WO2001094543A3 (en) 2002-06-20
EP1299118A4 (en) 2007-08-15
US6703513B1 (en) 2004-03-09
US20100016424A1 (en) 2010-01-21
US20040147592A1 (en) 2004-07-29
WO2001094543A2 (en) 2001-12-13
EP1299118A2 (en) 2003-04-09
US7560572B2 (en) 2009-07-14

Similar Documents

Publication Publication Date Title
AU2001274998A1 (en) Production and use of derivatized homoserine lactones
AU2001288299A1 (en) Electrochromic materials, devices and process of making
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
AU2002217926A1 (en) Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
AUPQ544900A0 (en) Treatment of cellulosic material
AU2001265141A1 (en) Multifunctional periodic cellular solids and the method of making thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002223589A1 (en) Production of polypropylene
AU2001294030A1 (en) Fibre and its production
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001280179A1 (en) Production and use of octafluoropropane
AU3553400A (en) Use and production of polypropylene
AU2002230606A1 (en) Glazing unit and method of making the same
AU2001281307A1 (en) Fluorescein-based metal sensors, and methods of making and using the same
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2001250886A1 (en) Materials having low dielectric constants and methods of making
AU2001216514A1 (en) Electrode material and capacitor
AU2001262556A1 (en) Provision of digital content
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU2001258533A1 (en) Construction of dies
AU2001284004A1 (en) Nitroderivatives of polysaccharides
AU2001265935A1 (en) Production of biohydrolysates
AU2002243284A1 (en) Jadeite and its production
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor